SLVRGEN® is a novel synergistic formulation for burns and wound treatment.
An innovative fusion of biotechnological and pharmaceutical components, SLVRGEN® is a topical gel consisting of recombinant human Epidermal Growth Factor (rhEGF) with Silver Sulfadiazine (SSD) and Chlorhexidine Gluconate (CHG) for faster healing of first- and second-degree burns.
Co-supplementation of rhEGF with SSD and CHG not only ensures faster wound healing, but also protects the cells from silver toxicity.
It is stable at room temperature (25°C).
To know more about SLVRGEN®, visit www.anamaybiotech.com